Pancreatic cancer is one of the deadliest malignancies in modern medicine, and its rise has turned quiet daily routines into ...

A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research ...

Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...

However, insights from the biomarkers in patients with pancreatic cancer (BIOPAC) study (NCT03311776) showed that higher levels of the inflammatory biomarkers interleukin (IL)-6, YKL-40, and C ...

The SHARON trial is a phase 1 study testing a new treatment called GO-4 for patients with advanced pancreatic cancer who have ...

UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...

Even as they develop at their primary site, pancreatic cancer cells are already expressing the genes that will determine ...

Pancreatic adenocarcinoma is by far the most common subtype of pancreatic cancer, but there are many other subtypes. Your pancreas is an organ behind your stomach that helps with digestion and hormone ...

Pancreatic cancer is often advanced by the time it’s diagnosed. It’s very common for it to spread to other parts of the body. Many people have advanced pancreatic cancer at the time of diagnosis.

Pancreatic cancer remains one of the most challenging cancers to detect early, contributing to its reputation as a silent disease with poor survival rates. The pancreas—a leaf-shaped organ tucked ...